NovoCure Ltd (NASDAQ: NVCR) closed the day trading at $11.64 down -3.32% from the previous closing price of $12.04. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 2.5 million shares were traded. NVCR stock price reached its highest trading level at $12.2831 during the session, while it also had its lowest trading level at $11.58.
Ratios:
For a better understanding of NVCR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 2.00 whereas as Long-Term Debt/Eq ratio is at 0.40.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $30.
Evercore ISI Upgraded its In-line to Outperform on December 02, 2024, whereas the target price for the stock was revised from $18 to $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Stafford Kristin sold 999 shares for $17.28 per share. The transaction valued at 17,259 led to the insider holds 3,054 shares of the business.
LEUNG GABRIEL sold 999 shares of NVCR for $17,297 on Jun 03 ’25. The Director now owns 81,229 shares after completing the transaction at $17.31 per share. On Jun 03 ’25, another insider, Madden Martin J., who serves as the Director of the company, sold 999 shares for $17.19 each. As a result, the insider received 17,176 and left with 18,674 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 1301340416 and an Enterprise Value of 1090070784. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07 while its Price-to-Book (P/B) ratio in mrq is 3.72. Its current Enterprise Value per Revenue stands at 1.73 whereas that against EBITDA is -6.862.
Stock Price History:
The Beta on a monthly basis for NVCR is 0.59, which has changed by -0.5013921 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, NVCR has reached a high of $34.13, while it has fallen to a 52-week low of $11.57. The 50-Day Moving Average of the stock is -32.22%, while the 200-Day Moving Average is calculated to be -42.28%.
Shares Statistics:
Over the past 3-months, NVCR traded about 1.37M shares per day on average, while over the past 10 days, NVCR traded about 1884460 shares per day. A total of 111.80M shares are outstanding, with a floating share count of 99.06M. Insiders hold about 11.39% of the company’s shares, while institutions hold 76.89% stake in the company. Shares short for NVCR as of 1752537600 were 4927495 with a Short Ratio of 3.61, compared to 1749772800 on 4944866. Therefore, it implies a Short% of Shares Outstanding of 4927495 and a Short% of Float of 6.959999999999999.
